The MYELOMA ALLY brand, founded in 2013 (United States), from 126 sister brands and 17477 competing brands. The MYELOMA ALLY brand is owned by Celgene, a company listed in New York. MYELOMA ALLY belongs to the Drug Manufacturers business sector.

MYELOMA ALLY is a brand of Celgene () Share price

Share price and profitability of the share Celgene (MYELOMA ALLY)

Buy Celgene share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Stock market history Celgene (MYELOMA ALLY)

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more